The Pharmaceutical Intellectual Property and Competition Law Review
Written By
Partner
UK
As one of our firm's most experienced intellectual property partners, specialising in transactional IP matters, I offer a wealth of knowledge to businesses at the cutting edge of research, development and technology, in a variety of sectors for which IP is of prime importance.
Partner
UK
A partner in our Competition & EU Law practice group based in London, I bring over 25 years' experience of providing solutions for our clients in highly regulated and technically complex markets.
Senior Associate
UK
I am a senior associate in the Intellectual Property Group in London, with a focus on regulatory and commercial matters primarily in the life sciences and healthcare sectors.
Related
Practices
Sectors
Regions
Countries
Offices
The Pharmaceutical Intellectual Property and Competition Law Review provides a practical overview of pharmaceutical intellectual property issues, including patent linkage and exclusivities, and related competition concerns. With a focus on recent developments, it is a useful tool for managing global risks in this area – analysing the key elements of the relevant legal and regulatory regimes across major jurisdictions worldwide.
Read the full chapter here
Latest insights
More Insights
A sneak peek into the draft NESRS: What sustainability reporting standards may non-EU parent companies expect?
Dec 24 2024
Guiding through ‘the maze of food labelling’ – The most recent European Court of Auditors’ special report
6 minutes Dec 20 2024
Loyalty Pays: CMA Confirms Genuine Savings for Supermarket Loyalty Scheme Members and Issues New Guidance on Consumer Law Compliance
4 minutes Dec 18 2024